IQVIA (NYSE:IQV) Shares Gap Down – What’s Next?

IQVIA Holdings Inc. (NYSE:IQV) gapped down before the market opened on Tuesday . The stock had previously closed at $204.64, but opened at $198.98. IQVIA shares last traded at $199.37, with a volume of 273,028 shares.

Analyst Ratings Changes

IQV has been the subject of a number of recent analyst reports. William Blair reaffirmed an “outperform” rating on shares of IQVIA in a report on Wednesday, December 11th. Deutsche Bank Aktiengesellschaft reduced their target price on IQVIA from $270.00 to $265.00 and set a “buy” rating for the company in a report on Friday, November 1st. Truist Financial reduced their target price on IQVIA from $265.00 to $261.00 and set a “buy” rating for the company in a report on Thursday, December 12th. The Goldman Sachs Group reduced their target price on IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a report on Friday, November 1st. Finally, Morgan Stanley reduced their target price on IQVIA from $280.00 to $265.00 and set an “overweight” rating for the company in a report on Monday, November 4th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, IQVIA presently has an average rating of “Moderate Buy” and a consensus target price of $255.82.

IQVIA Price Performance

The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The company has a 50-day simple moving average of $201.73 and a 200-day simple moving average of $221.71. The company has a market cap of $36.12 billion, a price-to-earnings ratio of 26.12, a PEG ratio of 2.05 and a beta of 1.48.

Hedge Funds Weigh In On IQVIA

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Laurel Wealth Advisors LLC grew its holdings in shares of IQVIA by 3.2% in the 4th quarter. Laurel Wealth Advisors LLC now owns 4,572 shares of the medical research company’s stock worth $898,000 after acquiring an additional 140 shares during the period. Fifth Third Wealth Advisors LLC grew its holdings in shares of IQVIA by 26.1% in the 4th quarter. Fifth Third Wealth Advisors LLC now owns 1,839 shares of the medical research company’s stock worth $361,000 after acquiring an additional 381 shares during the period. Community Trust & Investment Co. grew its holdings in shares of IQVIA by 4.9% in the 4th quarter. Community Trust & Investment Co. now owns 77,240 shares of the medical research company’s stock worth $15,178,000 after acquiring an additional 3,634 shares during the period. Cullen Investment Group LTD. grew its holdings in shares of IQVIA by 1.3% in the 4th quarter. Cullen Investment Group LTD. now owns 20,575 shares of the medical research company’s stock worth $4,043,000 after acquiring an additional 267 shares during the period. Finally, Pallas Capital Advisors LLC acquired a new stake in shares of IQVIA in the 4th quarter worth approximately $298,000. Institutional investors and hedge funds own 89.62% of the company’s stock.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.